How to Find PhD Supervisors in Pharmacy (and Get Funded)

Search find a PhD supervisor in pharmacy and most of what comes back is written for the PharmD, the professional degree that trains licensed pharmacists. That's not this. The PhD in Pharmaceutical Sciences, covering pharmacology, pharmaceutics, medicinal chemistry, and drug discovery, is a research doctorate that runs on grant funding and advisor fit, closer in structure to a biomedical sciences PhD than to a professional pharmacy degree. Confusing the two changes which funding pages, which admissions pages, and which professors you should actually be looking at.

A PhD in Pharmaceutical Sciences is not a PharmD, and the funding difference is the whole point

The PharmD is a four-year professional doctorate that licenses you to practice pharmacy, and it's typically funded the way professional degrees usually are, largely through tuition and loans rather than a guaranteed stipend. The PhD in Pharmaceutical Sciences is a research doctorate, usually five to six years, built around a funded lab and a dissertation, and it works structurally like other lab-based biomedical PhDs: you're not paying tuition, you're being paid a stipend to do research. Some schools also offer a combined PharmD/PhD track for students aiming at academic or industry research careers that use both clinical and lab training, and that combined path runs longer, commonly seven years and often closer to eight in practice, since it stacks the full PharmD curriculum on top of a full PhD. If you're searching for a funded PhD specifically, the standalone Pharmaceutical Sciences PhD or the PhD portion of a PharmD/PhD track is what you want, not a standalone PharmD application, which is a different kind of program entirely.

Most programs run you through lab rotations first, the same way biotech and biomedical sciences do

Pharmaceutical sciences PhD admissions mostly follow the umbrella model common across biomedical fields: you're admitted to the program, not to one named professor's lab, and you complete a set of rotations before committing to a thesis advisor. The University of Michigan's Pharmaceutical Sciences PhD has students rotate through faculty labs during the first year before being matched with a mentor at the end of the Winter term. UW-Madison runs three rotations of roughly four weeks each during the first semester. Wayne State's program also runs three rotations in the first semester, after which students and faculty each rank their preferences and the graduate director matches them. UCSF's Pharmaceutical Sciences and Pharmacogenomics program requires three lab rotations in the first year before a thesis lab is chosen. That means a pre-application email to a specific professor isn't securing an admission decision the way it might in a directly-admitted field, it's making your program-level application read as informed rather than generic, and giving yourself a head start on which labs are actually worth rotating through. Direct-entry alternatives do exist at some schools. UT Health San Antonio, for example, lets applicants choose between requesting direct placement in a specific lab or taking the rotation path, so it's worth checking a given program's admissions page rather than assuming every pharmaceutical sciences PhD works the same way.

NIGMS runs a training track built specifically for pharmacology, and it's closed to international applicants

The NIH institute most directly relevant here is NIGMS, the National Institute of General Medical Sciences, which funds basic pharmacological and pharmaceutical research and runs a predoctoral T32 training grant program organized around roughly a dozen broad research areas. Pharmacological Sciences is one of those named areas, alongside categories like Chemistry-Biology Interface and Molecular Medicine, and several departments have held NIGMS T32 funding in it for decades: Saint Louis University's Department of Pharmacology and Physiology has run NIGMS T32 training for 35 years, the University of Colorado Denver's Pharmacology Graduate Training Program is in its 34th year of NIGMS funding, and the University of Iowa and the University of Pennsylvania both run their own NIGMS-funded predoctoral pharmacology training grants. The catch is the one that runs through every NIH training mechanism: T32 trainees, like F31 individual fellows, must be a US citizen, US non-citizen national, or lawful permanent resident at the time of appointment. Temporary visa holders don't qualify, and no amount of application strength changes that. For 2026, the F31 stipend is $29,364 a year plus a tuition and fee allowance of up to $16,000, but if you're an international applicant, the eligibility line matters more than the dollar figure.

The named fellowships this field actually has, and which ones aren't citizenship-restricted

Pharmaceutical sciences has its own set of named funding sources outside the NIH training-grant system, and they don't all carry the same restriction. The American Foundation for Pharmaceutical Education runs a Pre-Doctoral Fellowship specifically for pharmaceutical sciences PhD students, covering pharmaceutics, pharmacology, manufacturing pharmacy, and medicinal chemistry, paying $11,000 a year for a new fellowship and $6,500 for a renewal year, open to students who've completed at least three semesters of graduate study with no more than three years left, including students in a joint PharmD/PhD track. Its fellowship is US-citizens-and-permanent-residents-only, the same restriction as the NIH mechanisms. The PhRMA Foundation runs predoctoral fellowships in Drug Discovery, Drug Delivery, Translational Medicine, and Value Assessment and Health Outcomes Research, paying $30,000 a year of stipend support for up to two years, and it's explicitly open to both US and non-US citizens, provided you're a full-time, in-residence student at an accredited US university. In 2026 the Foundation awarded more than $3.7 million across roughly 50 early-career researchers in these categories, later expanded to 65 awardees and over $4.6 million, up from 41 the year before. For students specifically working in medicinal chemistry, the American Chemical Society's Division of Medicinal Chemistry runs a Predoctoral Fellowship paying $20,000, four awarded in 2026, two of them sponsored by Genentech, open to PhD students in a Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry, or Chemistry department whose mentor is a division member, and its eligibility page states directly that applications from international students at US institutions are welcome. If you're coming into pharmaceutical sciences from a chemistry background, it's worth also reading our guide on how to find PhD supervisors in chemistry, since medicinal chemistry sits right at the overlap of the two fields and a fair number of applicants are searching both.

Checking whether a professor is actually active means checking the field's own journals, not just bioRxiv

Pharmaceutical sciences publishes primarily through its own named journals rather than a general biology outlet: the Journal of Pharmaceutical Sciences covers pharmaceutics, drug delivery, and pharmacokinetics; Molecular Pharmaceutics, an American Chemical Society journal running since 2004, covers the mechanistic side of drug delivery; Drug Metabolism and Disposition, published by the American Society for Pharmacology and Experimental Therapeutics, covers drug-metabolizing enzymes; and the International Journal of Pharmaceutics is one of the most-cited journals in the Pharmacy and Pharmacology category. bioRxiv does run a dedicated Pharmacology and Toxicology collection, and life-sciences preprinting overall has grown fast, with roughly 70 percent of bioRxiv preprints eventually appearing in a journal within two years, but preprint adoption took hold first and fastest in fields like evolutionary biology, genomics, and computational biology. A pharmaceutical sciences lab not posting to bioRxiv tells you very little, so check the field's own journals directly rather than treating bioRxiv activity as the signal. Pair that with NIH RePORTER, the free public database that lists NIH grant awards searchable by principal investigator and institution and defaults to currently active projects, to confirm a professor holds live funding through NIGMS, NIDA, or another relevant institute before you invest time writing them a specific email.

A practical search order

• Confirm you're looking at the PhD in Pharmaceutical Sciences, not a standalone PharmD, and if a program offers a PharmD/PhD track, check whether that's actually the path you want given the extra years it adds.
• Check whether your target program runs a rotation model and how many rotations, since that changes how much weight your application should put on naming one specific lab.
• If you're a US citizen or permanent resident, check whether the department holds active NIGMS T32 funding in Pharmacological Sciences, and separately whether you're a strong AFPE or F31 candidate.
• If you're an international applicant, focus your search on the PhRMA Foundation and ACS Medicinal Chemistry fellowships if your subfield fits, and on professors holding their own active NIGMS, NIDA, or NCI grants with an open assistantship line.
• Confirm a specific professor is actively publishing in the field's own journals and currently funded on NIH RePORTER before you write them, rather than relying on bioRxiv activity or an old lab page.

GradScoutFunding is built for that identification and outreach step: it searches professors by field and country, confirms they're actively publishing, and drafts a personalized first email grounded in their real recent paper for you to review and send yourself, it never sends anything automatically. Get started with 100 credits with no card required, and paid credit packs are one-time purchases that never expire.

Common questions